Details for N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carboxamide
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 123040-93-7 | ||
EC NO: | |||
Molecular Formula: | C17H20ClN3O3 | ||
Molecular Weight: | 349.812 | ||
Specification: | |||
InChI: | InChI=1/C17H20ClN3O3/c1-20-13-9-11(18)8-12(15(13)24-10-14(20)22)16(23)19-17-2-5-21(6-3-17)7-4-17/h8-9H,2-7,10H2,1H3,(H,19,23) | ||
Synonyms: | N-(1-AZABICYCLO[2.2.2]OCT-3-YL)-6-CHLORO-4-METHYL-3-OXO 3,4-DIHYDRO-2H-1,4-BENZOXAZINE-8-CARBOXAMIDE;Nazasetron Azasetron;(¡À)-N-(1-azabicyclo[2,2,2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride;Asasetron;6-chloro-4-methyl-3-oxo-N-quinuclidin-4-yl-1,4-benzoxazine-8-carboxamide;Azasetron [superceded rn];2H-1,4-Benzoxazine-8-carboxamide, N-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, monohydrochloride;N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carboxamide;2H-1,4-Benzoxazine-8-carboxamide,N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-; | ||
Molecular Structure: |